2nd Operationalize: Decentralized Clinical Trials Summit | September 7-9

By bringing together the world's leading Decentralized Clinical Trials thinkers, the 2nd Operationalize: Decentralized Clinical Trials Summit will clarify the complex issues through end-to-end remote, decentralized, and siteless clinical trial program operationalization. Through open discussion, sharing best-practice case studies, and removing the hypothetical: this meeting is your best chance to solve your challenges based on the wealth of experience collected in the last year of trial adaption.

Whether it's trial set-up, technological integration, negotiating with stakeholders, hybridization, patient communication, and choice provision: ensure you aren't repeating past mistakes by hearing global leaders recall their experience with a shared goal of providing you with pragmatic solutions to solve these complex hurdles.

Featuring real-life case studies and experiences as well as interactive panel discussions and virtual roundtables from the likes of PRA Health Sciences, Boehringer Ingleheim, Janssen, Decentralized Trials and Research Alliance, and the Digital Medicine Society, this is your opportunity to find the answers to your most burning decentralized clinical trials challenges.

Join us to lead the industry by offering patients more flexibility through decentralized trials.

URLs:
Tickets: https://go.evvnt.com/772259-2?pid=176
Brochure: https://go.evvnt.com/772259-3?pid=176

Prices:
FREE PASS: Drug Developers, Research Institutions and Non-for-profit: USD 0.0,
Conference + 2 Workshops - Solution Provider: USD 3099.0,
Conference + 1 Workshop - Solution Provider: USD 2699.0,
Conference Only - Solution Provider: USD 2299.0

Speakers: Isaac Rodriguez-Chavez, Senior Vice President of Scientific and Clinical Affairs, PRA Health Sciences, Steven R. Cummings, Executive Director, San Francisco Coordinating Center, California Pacific Medical Center Research Institute, Amir Lahav, Healthcare Intelligence and Digital Transformation Consultant, Mitsubishi Tanabe Pharma America, Tracey Robertson, Head of Digital Trials - Global Biostatistics and Data Sciences, Boehringer Ingelheim, Rachel Chasse, Director of Innovation, Digital Medicine Society (DiMe), Daniel R Karlin, MD MA Chief Medical Officer, MindMed, Arturo Loaiza-Bonilla, Enterprise Director of Research, Cancer Treatment Centers of America, Mary C. Birmingham, PharmD, Director, Clinical Scientist, Janssen Scientific Affairs LLC, Rebecca Jackson, Clinical R and D SME - Clinical Data IT, Clinical Trials, Clinical Supply Chain, Johnson and Johnson, Jim Ternyila, Senior Business Relationship Manager - Digital Therapeutics, AstraZeneca, Amy Bohn, Study Operations Specialist, DCT Clinical Development, Bayer, Erica Lawson, Director, Applied Innovation, Otsuka, Arthur Combs, MD President, FutureTech Strategies, Inc., Craig Lipset, Co-Chair, Decentralized Trials and Research Alliance (DTRA), Jim Hacunda, R and D Digital Strategy Lead, Takeda, Vera Rulon, Founder and President, Tir Health Advisors, Ruth Schneider, MD, Assistant Professor of Neurology, University of Rochester, Gunilla Andrew-Nielsen, Head of Department of Clinical Trials and Special Permissions, Medical Products Agency, Jen Horonjeff, Founder and CEO, Savvy Cooperative, Brandon Maggio, Director of Digital and Process Optimization, GSK, Shoibal Datta, Head, R and D Digital Strategy Group, Data Sciences Institute, Takeda

Time: 08:45 - 16:00